Evidence map›Paper›PMID 22587993›Full record

ArticleJournal of molecular and cellular cardiology2012

Non-neuronal cholinergic machinery present in cardiomyocytes offsets hypertrophic signals.

Cibele Rocha-Resende, Ashbeel Roy, Rodrigo Resende, Marina S Ladeira, Aline Lara, Enéas Ricardo de Morais Gomes, Vania F Prado, Robert Gros, Cristina Guatimosim, Marco A M Prado and 1 more

Open access · greenAbstract read
In one paragraph

Article in Journal of molecular and cellular cardiology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 107 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. DbhNature communications · 2023
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Cibele Rocha-ResendeDepartment of Physiology and Biophysics, Institute of Biological Sciences, Universidade Federal de Minas Gerais, Belo Horizonte, MG, CEP 31270-901, Brazil. cibeler@ufmg.br
Ashbeel Roy
Rodrigo Resende
Marina S Ladeira
Aline Lara
Enéas Ricardo de Morais Gomes
Vania F Prado
Robert Gros
Cristina Guatimosim
Marco A M Prado
Silvia Guatimosim
Universidade Federal de Minas Gerais · BRWestern University · CA

Funding

Decreased Cholinergic Tone and Mitochondrial Dysfunction in HeartR03TW008425 · FIC · UNIVERSITY OF MARYLAND BALTIMORE · PI LEDERER, WILLIAM JONATHAN · 2011 to 2014
$166k
CIHRFIC NIH HHS R03 TW008425FIC NIH HHS R03TW008425
6 · The paper itself

Abstract

Recent work has provided compelling evidence that increased levels of acetylcholine (ACh) can be protective in heart failure, whereas reduced levels of ACh secretion can cause heart malfunction. Previous data show that cardiomyocytes themselves can actively secrete ACh, raising the question of whether this cardiomyocyte derived ACh may contribute to the protective effects of ACh in the heart. To address the functionality of this non-neuronal ACh machinery, we used cholinesterase inhibitors and a siRNA targeted to AChE (acetylcholinesterase) as a way to increase the availability of ACh secreted by cardiac cells. By using nitric oxide (NO) formation as a biological sensor for released ACh, we showed that cholinesterase inhibition increased NO levels in freshly isolated ventricular myocytes and that this effect was prevented by atropine, a muscarinic receptor antagonist, and by inhibition of ACh synthesis or vesicular storage. Functionally, cholinesterase inhibition prevented the hypertrophic effect as well as molecular changes and calcium transient alterations induced by adrenergic overstimulation in cardiomyocytes. Moreover, inhibition of ACh storage or atropine blunted the anti-hypertrophic action of cholinesterase inhibition. Altogether, our results show that cardiomyocytes possess functional cholinergic machinery that offsets deleterious effects of hyperadrenergic stimulation. In addition, we show that adrenergic stimulation upregulates expression levels of cholinergic components. We propose that this cardiomyocyte cholinergic signaling could amplify the protective effects of the parasympathetic nervous system in the heart and may counteract or partially neutralize hypertrophic adrenergic effects.

Indexed as

AcetylcholineAcetylcholinesteraseAnimalsAtropineCardiomegalyCell MovementCells, CulturedIsoproterenolMiceMuscarinic AntagonistsMyocytes, CardiacNitrogen OxidesPhenylephrineRatsRNA, Small InterferingAcetylcholineAcetylcholinesteraseAtropineIsoproterenolMuscarinic AntagonistsNitrogen OxidesPhenylephrineRNA, Small Interfering

Identifiers

PMID22587993
PMCPMC3806714
OpenAlexW2133939865

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.